martes, 22 de febrero de 2022

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 | NEJM

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 | NEJM

No hay comentarios:

Publicar un comentario